BriefWeWork’s Adam Neumann Invests in Ehud Barak’s Cannabis Venture
Neumann invested $5 million in Tel Aviv-listed medical cannabis company InterCure, chaired by former Israeli Prime Minister Barak
InterCure’s stock was up 5.43% by market close Wednesday.
In October, Intercure announced it raised $12 million (NIS 45 million) in private placement. Half of the sum was invested by the company’s controlling shareholder Alex Rabinovich, who holds 38.48% of InterCure’s stock, and the rest by Gary Fegel, founder of Zurich-based GMF Capital LLC, who holds a 5% stake.